Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Myasthenia gravis: the future is here
Henry J. Kaminski, Patricia Sikorski, S. Isabel Coronel, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 12
Open Access | Times Cited: 10

Showing 10 citing articles:

Elucidating Genetic Intersections: Co-Differentially Expressed Genes in Myasthenia Gravis and Idiopathic Inflammatory Myopathies and Their Role in Comorbid Pathogenesis
Wenqu Yang, Liang Feng
Heliyon (2025) Vol. 11, Iss. 1, pp. e41442-e41442
Open Access
A case of relapsed gAChR-positive autoimmune autonomic ganglionopathy treated by plasma exchange and mycophenolate mofetil
Zhijie Lü, Xiaojie Cao, Mingyu Wang, et al.
Frontiers in Neurology (2025) Vol. 15
Open Access
Preoperative multiclass classification of thymic mass lesions based on radiomics and machine learning
Yan Zhu, Li Wang, Aichao Ruan, et al.
Cancer Imaging (2025) Vol. 25, Iss. 1
Open Access
Antibodies in neurological diseases: Established, emerging, explorative
Lucie Y. Li, Amelya Keles Slevogt, Marie A. Homeyer, et al.
Immunological Reviews (2024)
Open Access | Times Cited: 4
Can Non‐Thymomatous Late‐Onset Myasthenia Gravis Benefit From Thymectomy? A Systematic Review and Meta‐Analysis
Jiaxin Chen, Chunhua Su, Huiyu Feng, et al.
European Journal of Neurology (2025) Vol. 32, Iss. 3
Open Access
Telitacicept as an alternative to non-steroidal immunosuppressive therapies in the treatment of myasthenia gravis: a study on clinical efficacy and steroid-sparing effect
Zheyu Fang, Yuan Zhang, Yu Zhang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Efgartigimod improves non-AChR generalized Myasthenia Gravis: a real world experience
Carlo Antozzi, Rita Frangiamore, Elena Rinaldi, et al.
Neurological Sciences (2025)
Closed Access
Risk–Benefit Analysis of Novel Treatments for Patients with Generalized Myasthenia Gravis
A. Gordon Smith, Gil I. Wolfe, Ali A. Habib, et al.
Advances in Therapy (2024) Vol. 41, Iss. 12, pp. 4628-4647
Open Access | Times Cited: 3
The Impact of Epstein-Barr Virus on Autoimmune Neuromuscular Disorders: A Comparative Study of Myasthenia Gravis and Guillain–Barre Syndrome
Anu Shibi Anilkumar, Ramakrishnan Veerabathiran
Current Treatment Options in Neurology (2024) Vol. 26, Iss. 11, pp. 495-507
Closed Access | Times Cited: 2
Towards personalized management of myasthenia gravis phenotypes: From the role of multi-omics to the emerging biomarkers and therapeutic targets
Carmela Rita Balistreri, Claudia Vinciguerra, Daniele Magro, et al.
Autoimmunity Reviews (2024) Vol. 23, Iss. 12, pp. 103669-103669
Closed Access | Times Cited: 2
Immunomodulatory effect of compound Xuelian capsule on experimental autoimmune myasthenia gravis in mice
Fukai Gong, Jianhua Wu, Min Jiao, et al.
Pharmacological Research - Modern Chinese Medicine (2024), pp. 100549-100549
Open Access
The Role of Exosomes in Central Immune Tolerance and Myasthenia Gravis
Hanlu Zhang, Siyuan Luan, Fuqiang Wang, et al.
Immunological Investigations (2024), pp. 1-23
Closed Access
Page 1

Scroll to top